Media and News
PharmaNova to present at UK conference, BioPartnering Europe 2007.
Rochester, New York: August 17, 2007.
PharmaNova Inc. announced today that the company will be presenting at the 15th anniversary meeting of BioPartnering Europe (http://www.techvision.com/bpe/), to be held in London, October 7-9, 2007. As part of the Open House sessions a podium presentation will be made by Rodney Brown, President of PharmaNova and our exhibit booth will be manned for the morning of Tuesday 9th October. Presentation materials will be accessible via this website at the time of the meeting.
PharmaNova Inc. is a privately held, specialty drug development company founded on the re-purposing and enhancement of known drugs using our proprietary nanoparticle and complementary formulation technologies. We specialize in low risk, fast to market products and generate revenue from partnering and licensing strategies with commercialization partners worldwide. PharmaNova’s current focus is on extraordinary value products in Women’s Health and adjacent areas, including a non-hormonal treatment for hot flashes associated with the menopause and for vasomotor symptoms secondary to the treatment of certain cancers. Our platform nanoparticle technology is directed at the development of new and improved cancer chemotherapeutics.
PharmaNova: Technology for Better Medicines
« Back to Media
Members of the media wishing to learn more about Pharmanova should contact: Rodney Brown, President. Rodney.Brown@pharmanovaco.com, (585)-413-4721.